K
Koninklijke Philips NV
F:PHI1
Koninklijke Philips NV
F:PHI1
Price:
27.87
EUR
13.94%
Market Cap:
€26.1B
Relative Value
There is not enough data to reliably calculate the relative value of PHI1.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHI1
Relative Value
Base Case
Not Available
Multiples Across Competitors
PHI1 Competitors Multiples
Koninklijke Philips NV Competitors
Koninklijke Philips NV Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NL |
K
|
Koninklijke Philips NV
F:PHI1
|
17.5B EUR | 1 | -21.8 | 25 | -63.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
194.9B USD | 4.4 | 29.9 | 16.9 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.7B USD | 17.6 | 61.9 | 47 | 57.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.7B USD | 5.5 | 42.7 | 21.7 | 26.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.4B USD | 3.8 | 27.4 | 15.3 | 22.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.1B USD | 5.5 | 38 | 22.6 | 30.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.5B EUR | 1.9 | 21.4 | 11.9 | 16.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.8B USD | 12 | 48.9 | 34.9 | 38.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.9B USD | 2.2 | 29.2 | 11.2 | 19 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD | 7.6 | 32.8 | 23.3 | 25.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
38.7B USD | 7.2 | 26.1 | 18.4 | 20.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
